Ileitis promotes MASLD progression via bile acid modulation and enhanced TGR5 signaling in ileal CD8+ T cells

• Published in: Journal of hepatology Vol. 80; no. 5; pp. 764 - 777
• Main Authors: Zheng, Chang, Wang, Lei, Zou, Tianhui, Lian, Senlin, Luo, Jiajing, Lu, Yijun, Hao, Hanbing, Xu, Yuejie, Xiang, Ying, Zhang, Xiaoqi, Xu, Guifang, Zou, Xiaoping, Jiang, Runqiu
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.05.2024
• Subjects: bile acids; CD8+T cells; Crohn’s disease; FXR; metabolic dysfunction associated steatotic liver disease; TGR5; TGR5; FXR; CD8+T cells; metabolic dysfunction associated steatotic liver disease; bile acids; Crohn’s disease; CD8(+)T cells
• ISSN: 0168-8278; 1600-0641
• DOI: 10.1016/j.jhep.2023.12.024

Clinical evidence substantiates a link between inflammatory bowel disease, particularly Crohn's disease (CD), and metabolic dysfunction-associated steatotic liver disease (MASLD). This study aims to explore the underlying molecular mechanisms responsible for this association. MASLD was induced by administering high-fat and western diets, while inflammatory bowel disease was induced using DSS (dextran sulfate sodium) and the Il10 knockout (KO) mouse model. The investigation into the role of secondary bile acids (SBAs) in ileitis involved employing metagenomic sequencing, conducting metabolomics detection, performing fecal microbiota transplantation, and constructing CD8+ T cell-specific gene knockout mice. In MASLD+DSS and Il10 KO MASLD mice, we observed ileitis characterized by T-cell infiltration and activation in the terminal ileum. This condition resulted in decreased bile acid levels in the portal vein and liver, inhibited hepatic farnesoid X receptor (FXR) activation, and exacerbated MASLD. Metagenomic and metabolomic analysis of ileal contents revealed increased Clostridium proliferation and elevated SBA levels in MASLD-associated ileitis. Experiments using germ-free mice and fecal microbiota transplantation suggested an association between SBA and MASLD-related ileitis. In vitro, SBAs promoted CD8+ T-cell activation via the TGR5, mTOR, and oxidative phosphorylation pathways. In vivo, TGR5 KO in CD8+ T cells effectively alleviated ileitis and reversed the MASLD phenotype. Clinical data further supported these findings, demonstrating a positive correlation between ileitis and MASLD. MASLD-induced changes in intestinal flora result in elevated levels of SBAs in the ileum. In the presence of a compromised intestinal barrier, this leads to severe CD8+ T cell-mediated ileitis through the TGR5/mTOR/oxidative phosphorylation signaling pathway. Ileitis-induced tissue damage impairs enterohepatic circulation, inhibits hepatic FXR activation, and exacerbates the MASLD phenotype. Our study provides a comprehensive investigation of the interplay and underlying mechanisms connecting ileitis and metabolic dysfunction-associated steatotic liver disease (MASLD). Secondary bile acids produced by intestinal bacteria act as the critical link between MASLD and ileitis. Secondary bile acids exert their influence by disrupting liver lipid metabolism through the promotion of CD8+ T cell-mediated ileitis. In future endeavors to prevent and treat MASLD, it is essential to thoroughly account for the impact of the intestinal tract, especially the ileum, on liver function via the enterohepatic circulation. [Display omitted] •There is an interaction between Crohn’s disease and MASLD.•MASLD switches intestinal flora and ileal contents to an environment rich in secondary bile acids.•Secondary bile acids trigger CD8+T cell-mediated ileitis through the TGR5/mTOR/OXPHOS pathway.•Ileitis inhibited hepatic FXR activation and promoted MASLD.